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Background
Many patients with mild–moderate COPD (chronic
obstructive pulmonary disease), are asymptomatic. Since
expressed symptoms are usually mild and mostly attribu-
ted to age, they are often underestimated [1,2]. Thus early
COPD patients usually remain undiagnosed [3]. The aim
of the study is to evaluate the rates of undiagnosed COPD
cases in early stages of the disease (stage I and II according
to GOLD classification), [4] in our smoking cessation pro-
gram and to assess the effectiveness of COPD diagnosis as
a motivational tool for quitting smoking.
Materials and methods
551 current smokers, aged ≥18 years old, attended volunta-
rily the smoking cessation program in our outpatient smok-
ing cessation clinic. All smokers performed spirometry.
Behavioral counseling and pharmacotherapy with vareni-
cline were administered to all participants.
Results
During the study, 85 of 551 smokers were diagnosed for
COPD. Only 5 of them were previously diagnosed with
the disease (2 in stage II, 2 in stage III and 1 in stage IV).
None of them reported symptoms. Smoking abstinence
rates at 3 months was recorded. Overall smoking cessa-
tion rates three months after behavioral counseling was
55% (n=303). This percentage was higher in first diag-
nosed COPD patients, as shown in Table 1.
Conclusions
A smoking cessation program is a great opportunity to
identify undiagnosed COPD cases. COPD diagnosis is
an effective motive to quit smoking. Smoking cessation
combined with treatment based on COPD severity can
modify the progression of the disease. Namely the rate
of yearly FEV1 decline and COPD exacerbations are
reduced after smoking cessation and patients’ health
related quality of life is improved. The above effects are
maximized when smoking cessation is achieved in early
COPD stages [5,6]
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Table 1 COPD smokers that attended our Smoking
Cessation Clinic
COPD stages Ι ΙΙ ΙΙΙ IV
n 39 35 11 1
First diagnosis 39 33 9 0
Abstinence rates
after 3 months*
30 (76.9%) 30 (85.79%) 7 (63.6%) 1 (100%)
* Abstinence rates are referred to the summation of old and new COPD cases
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